ホーム > 鈴木裕之/ Suzuki, Hiroyuki

鈴木裕之

ALUMNI 2025年3月現在、筑波大学が主たる所属機関ではありません

Suzuki, Hiroyuki

東北大学 , 大学院医学系研究科 , 准教授
Tohoku University , Graduate School of Medicine , Associate Professor

http://www.md.tsukuba.ac.jp/epatho/

http://www.md.tsukuba.ac.jp/younginit/

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

41. EMab-300 Detects Mouse Epidermal Growth Factor Receptor-Expressing Cancer Cell Lines in Flow Cytometry Nohara Goto; Hiroyuki Suzuki; Tomohiro Tanaka; Kenichiro Ishikawa (+2 著者) Yukinari Kato
Antibodies 12: 42 (2023) Semantic Scholar
42. Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C44Mab-18 for Immunohistochemical Analysis against Oral Squamous Cell Carcinomas Kenichiro Ishikawa; Hiroyuki Suzuki; Mika K. Kaneko; Yukinari Kato
Current Issues in Molecular Biology 45: 5248 (2023) Semantic Scholar
43. A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications. Hiroyuki Suzuki; Kaishi Kitamura; Nohara Goto; Kenichiro Ishikawa (+3 著者) Yukinari Kato
International journal of molecular sciences 24: (2023) Semantic Scholar
44. Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas. Yuma Kudo; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
Antibodies (Basel, Switzerland) 12: (2023) Semantic Scholar
45. Identification of the Binding Epitope of an Anti-Mouse CCR6 Monoclonal Antibody (C6Mab-13) Using 1× Alanine Scanning. Tomohiro Tanaka; Mayuki Tawara; Hiroyuki Suzuki; Mika K KanekoYukinari Kato
Antibodies (Basel, Switzerland) 12: (2023) Semantic Scholar
46. A Novel Anti-CD44 Variant 9 Monoclonal Antibody C44Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers. Mayuki Tawara; Hiroyuki Suzuki; Nohara Goto; Tomohiro Tanaka (+1 著者) Yukinari Kato
Current issues in molecular biology 45: 3658 (2023) Semantic Scholar
47. Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies (C3Mab-6 and C3Mab-7). Nami Tateyama; Teizo Asano; Tomohiro Tanaka; Yu Isoda (+7 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 42: 68 (2023) Semantic Scholar
48. Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas Hiroyuki Suzuki; Kazuki Ozawa; Tomohiro Tanaka; Mika K. KanekoYukinari Kato
Biomedicines 11: (2023) Semantic Scholar
49. Development of Highly Sensitive Anti-Mouse CD39 Monoclonal Antibodies C39Mab-1 and C39Mab-2 for flow cytometry Hiroyuki Suzuki; Yuma Kudo; Mayuki Tawara; Nohara Goto (+7 著者) Yukinari Kato
(2023)
50. Development of Highly Sensitive Anti-Mouse CD39 Monoclonal Antibodies C39Mab-1 and C39Mab-2 for flow cytometry Hiroyuki Suzuki; Yuma Kudo; Mayuki Tawara; Nohara Goto (+7 著者) Yukinari Kato
(2023)
51. Development of Highly Sensitive Anti-Mouse CD39 Monoclonal Antibodies C39Mab-1 and C39Mab-2 for flow cytometry Hiroyuki Suzuki; Yuma Kudo; Mayuki Tawara; Nohara Goto (+7 著者) Yukinari Kato
(2023)
52. Development of Highly Sensitive Anti-Mouse CD39 Monoclonal Antibodies C39Mab-1 and C39Mab-2 for flow cytometry Hiroyuki Suzuki; Yuma Kudo; Mayuki Tawara; Nohara Goto (+7 著者) Yukinari Kato
(2023)
53. Epitope Mapping of the Novel Anti-Human CCR9 Monoclonal Antibody (C9Mab-11) by 2 × Alanine Scanning. Yu Isoda; Tomohiro Tanaka; Hiroyuki Suzuki; Teizo Asano (+6 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 42: 73 (2023) Semantic Scholar
54. Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C44Mab-108 for Immunohistochemistry. Hiroyuki Suzuki; Tomohiro Tanaka; Nohara Goto; Mika K KanekoYukinari Kato
Current issues in molecular biology 45: 1875 (2023) Semantic Scholar
55. Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C44Mab-9 for Multiple Applications against Colorectal Carcinomas. Ryo Ejima; Hiroyuki Suzuki; Tomohiro Tanaka; Teizo Asano (+1 著者) Yukinari Kato
International journal of molecular sciences 24: (2023) Semantic Scholar
56. Epitope Mapping of an Anti-EpCAM Monoclonal Antibody (EpMab-37) Using the Alanine Scanning Method. Guanjie Li; Hiroyuki Suzuki; Tomohiro Tanaka; Teizo Asano (+2 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 42: 41 (2023) Semantic Scholar
57. Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models. Guanjie Li; Hiroyuki Suzuki; Tomokazu Ohishi; Teizo Asano (+6 著者) Yukinari Kato
International journal of molecular medicine 51: (2023) Semantic Scholar
58. Determination of the Binding Epitope of an Anti-Mouse CCR9 Monoclonal Antibody (C9Mab-24) Using the 1× Alanine and 2× Alanine-Substitution Method. Hiyori Kobayashi; Teizo Asano; Tomohiro Tanaka; Hiroyuki Suzuki (+1 著者) Yukinari Kato
Antibodies (Basel, Switzerland) 12: (2023) Semantic Scholar
59. Establishment of a Sensitive Monoclonal Antibody Against Mouse CCR9 (C₉Mab-24) for Flow Cytometry Hiyori Kobayashi; Teizo Asano; Hiroyuki Suzuki; Tomohiro Tanaka (+2 著者) Yukinari Kato
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2022) Semantic Scholar
60. Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry Nami Tateyama; Teizo Asano; Hiroyuki Suzuki; Guanjie Li (+3 著者) Yukinari Kato
Antibodies 11: 75 (2022) Semantic Scholar

« 1 2 3 4 5 … 9 »

1. あなたのラボから薬を生み出すアカデミア創薬の実践 : all Japan体制の先端技術支援を利用した創薬の最前線善光, 龍哉; 辻川, 和丈 (担当:分担執筆, 範囲:CBIS法による高感度抗体の作製)
羊土社 2024年2月 (ISBN: 9784758104166)
2. がんゲノム医療時代の分子腫瘍学鈴木裕之; 後藤のはら; 加藤光保 (担当:分担執筆, 範囲:TGF-β経路)
文光堂 2022年4月
3. 炎症メディエーター TGF-β 鈴木,裕之; 青山,知恵; 加藤,光保 (担当:共著)
日本臨床 2009年5月
4. TGF-betaシグナル伝達系とがん治療鈴木裕之; 中条友香; 加藤光保 (担当:監修)
南山堂 2008年9月
5. TGF-βシグナル伝達とがん治療鈴木裕之; 中条友香; 加藤光保 (担当:分担執筆)
がんの分子標的治療 2008年6月
6. Negative regulation of the TGF-β family signal pathway by inhibitory Smads and their involvement in cancer and fibrosis. Itoh S; Suzuki H; Itoh F; Miyazono K; Kato M (担当:共著)
Humana Press Inc. 2008年
7. IGFBP 鈴木裕之; 加藤光保 (担当:監修)
サイトカイン・増殖因子用語ライブラリー / 羊土社 2005年3月
8. TGF-betaシグナルと疾患鈴木裕之; 宮園浩平 (担当:監修)
シグナル伝達研究2003 シグナル伝達研究2003 羊土社 2003年1月

1. THG-1 overexpression stabilizes β-catenin via antagonizing NRBP1 in esophageal squamous cell carcinoma Hwang, Jongchan; Suzuki, Hiroyuki; Zhang, Jing; Vasudevan, Prasanna; Dijke, Peter ten; Kato, Mitsuyasu
第79回日本癌学会学術総会 2020年10月1日
2. THG-1/TSC22D4による細胞老化の制御鈴木裕之; 加藤光保
第79回日本癌学会学術総会 2020年10月1日
3. THG-1はHIF-1alphaの安定化を介して腫瘍の進行を促進する鄭齢; 加藤, 光保; 鈴木裕之
第3回がん三次元培養研究会 2019年11月18日
4. Regulation of c-MYC transcriptional activity by transforming growth factor-beta 1–stimulated clone 22 Suzuki, SHiroyuki; Kato, Mitsuyasu
第78回日本癌学会学術総会 2019年9月26日
5. Screening of macrocyclic peptide against CD44 Goto, Nohara; HIPOLITO; CHRISTOPHER; Suzuki, Hiroyuki; Kato, Mitsuyasu
第78回日本癌学会学術総会 2019年9月26日
6. Oncogenic functions of TGFβ-stimulated clone-22 families
STINT Special Symposium on the Sweden-Japan 150 Anniversary Grant 2019年1月19日招待有り
7. Screening of macrocyclic peptide against CD44s Goto, Nohara; Yin, Yizhen; Hipolito, Christopher John; Suzuki, Hiroyuki; Suga, Hiroaki; Kato, Mitsuyasu; Heldin, Paraskevi; Constantinos Kolliopoulos; Karalis, Theodoros
第10回国際ペプチドシンポジウム／第55回ペプチド討論会 2018年12月3日
8. THG-1, a novel oncogene in tumor angiogenesis Zheng, Ling; Suzuki, Hiroyuki; Kato, Mitsuyasu
第41回日本分子生物学会年会 2018年11月28日
9. 乳がん細胞におけるGPNMBの幹細胞性誘導作用沖田結花里; 陳晨; 鈴木裕之; 加藤, 光保
第77回日本癌学会学術総会 2018年9月27日
10. 扁平上皮がん進展におけるTHG-1/Tsc22D4の機能鈴木裕之; 加藤, 光保
第77回日本癌学会学術総会 2018年9月27日
11. 3D imaging analysis of the promotion process from beta -catenin accumulated crypts to colonic adenomas in mice model Kase, Kazuo; Saito, Nobuko; Iwasaki, Hideaki; Hiroshima, Kenzo; Okita, Yukari; Watanabe, Yukihide; Suzuki, Hiroyuki; Kato, Mitsuyasu
日本癌学会学術総会 2018年9月27日
12. Roles of the interaction between THG-1 and NRBP1 in the development of esophageal squamous cell carcinoma Hwang, Jongchan; Miura, Mayuka; Suzuki, Hiroyuki; Djike, Peter ten; Kato, Mitsuyasu
Tsukuba Global Science Week 2018 2018年9月20日
13. 扁平上皮がんの発生病理鈴木裕之
第104回日本病理学会総会 2016年招待有り
14. Roles of THG-1/Tsc22D4 in squamous cell carcinoma development Hiroyuki Suzuki
Tsukuba-UCI Science Partnership Conference 2015年12月10日
15. Roles of THG-1/Tsc22D4 in squamous cell carcinoma development Hiroyuki Suzuki
Joint International Symposium on TGF-family and Cancer 2015年1月12日招待有り
16. Hypoxia and oxidative stress resistance in squamous cell carcinoma Hiroyuki Suzuki
Annual meeting of Hypoxia 2014年11月22日招待有り
17. Roles of THG-1/Tsc22D4 in tumor development Hiroyuki Suzuki
TGF-beta meeting, Netherland 2014 2014年5月9日
18. Roles of THG-1/Tsc22D4 in tumorigenesis Hiroyuki Suzuki
TGF-beta meeting, Sweden, 2013 2013年
19. TGF-β suppresses transcription of HO-1 gene through induction of MafK and Bach1. Yukari,Okita; Hiroyuki,Suzuki; Mitsuyasu,Kato
Leading Graduate Schools International Conference 2010年11月1日
20. Tsc-22 and TMEPAI; target genes of TGF-beta signaling possibly involved in cancer development Kato, M; Suzuki, H; Watanabe.Y; Itoh.S
*EMPTY*____ 2007年9月